Report period | 2018 | 2019 | 2020 | 2021 | 2022 | Q2 23 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, $ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
CE:US | Celanese Corporation | Common share | - | US1508701034 | $133.1 |
Company name | Celanese |
---|---|
Tags | #s&p500 index |
Sector | Materials / Materials / Chemicals / Commodity Chemicals |
Business address | 222 W. LAS COLINAS BLVD., SUITE 900N IRVING TX 75039-5421 972-443-4000 |
Mailing address | 222 W. LAS COLINAS BLVD., SUITE 900N IRVING TX 75039-5421 |
Website | www.celanese.com |
Information disclosure | www.sec.gov |